Arch Total Current Liabilities vs Total Cash From Operating Activities Analysis

ARCH Stock  CAD 1.77  0.05  2.91%   
Arch Biopartners financial indicator trend analysis is way more than just evaluating Arch Biopartners prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Arch Biopartners is a good investment. Please check the relationship between Arch Biopartners Total Current Liabilities and its Total Cash From Operating Activities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arch Biopartners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Total Current Liabilities vs Total Cash From Operating Activities

Total Current Liabilities vs Total Cash From Operating Activities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Arch Biopartners Total Current Liabilities account and Total Cash From Operating Activities. At this time, the significance of the direction appears to have very week relationship.
The correlation between Arch Biopartners' Total Current Liabilities and Total Cash From Operating Activities is 0.25. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Total Cash From Operating Activities in the same time period over historical financial statements of Arch Biopartners, assuming nothing else is changed. The correlation between historical values of Arch Biopartners' Total Current Liabilities and Total Cash From Operating Activities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Arch Biopartners are associated (or correlated) with its Total Cash From Operating Activities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Cash From Operating Activities has no effect on the direction of Total Current Liabilities i.e., Arch Biopartners' Total Current Liabilities and Total Cash From Operating Activities go up and down completely randomly.

Correlation Coefficient

0.25
Relationship DirectionPositive 
Relationship StrengthVery Weak

Total Current Liabilities

Total Current Liabilities is an item on Arch Biopartners balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Arch Biopartners are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Cash From Operating Activities

Most indicators from Arch Biopartners' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Arch Biopartners current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arch Biopartners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Selling General Administrative is likely to climb to about 763.7 K in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 109.4 K in 2024.
 2021 2022 2023 2024 (projected)
Research Development1.3M2.2M2.5M2.7M
Interest Expense309.3K358.9K412.8K433.4K

Arch Biopartners fundamental ratios Correlations

0.320.45-0.570.150.66-0.60.730.450.450.360.030.560.640.94-0.130.580.650.920.40.590.260.55-0.050.4-0.61
0.320.2-0.270.030.3-0.170.29-0.04-0.040.010.020.160.270.3-0.030.190.280.40.110.320.780.08-0.010.11-0.27
0.450.2-0.850.270.87-0.790.360.80.80.30.020.840.910.65-0.220.690.890.320.950.140.490.63-0.750.95-0.78
-0.57-0.27-0.85-0.33-0.970.97-0.69-0.77-0.77-0.5-0.25-0.92-0.97-0.690.3-0.9-0.97-0.39-0.88-0.58-0.43-0.820.46-0.880.99
0.150.030.27-0.330.32-0.490.130.440.440.90.120.030.320.31-0.990.310.340.120.340.24-0.250.72-0.180.3-0.32
0.660.30.87-0.970.32-0.940.70.760.760.460.230.910.990.8-0.290.91.00.530.880.590.440.78-0.550.88-0.96
-0.6-0.17-0.790.97-0.49-0.94-0.69-0.8-0.8-0.66-0.21-0.87-0.94-0.720.47-0.9-0.94-0.41-0.85-0.61-0.26-0.910.4-0.840.97
0.730.290.36-0.690.130.7-0.690.420.420.350.170.660.680.71-0.120.690.680.640.390.880.280.58-0.080.39-0.77
0.45-0.040.8-0.770.440.76-0.80.421.00.480.130.740.820.64-0.40.780.810.190.870.330.170.72-0.620.87-0.73
0.45-0.040.8-0.770.440.76-0.80.421.00.480.130.740.820.64-0.40.780.810.190.870.330.170.72-0.620.87-0.73
0.360.010.3-0.50.90.46-0.660.350.480.480.20.230.440.42-0.870.480.470.240.390.42-0.210.890.010.36-0.51
0.030.020.02-0.250.120.23-0.210.170.130.130.20.140.20.05-0.120.370.22-0.020.190.43-0.260.19-0.020.19-0.25
0.560.160.84-0.920.030.91-0.870.660.740.740.230.140.920.660.00.870.910.370.870.470.450.63-0.510.88-0.91
0.640.270.91-0.970.320.99-0.940.680.820.820.440.20.920.8-0.290.891.00.490.920.540.440.77-0.610.92-0.95
0.940.30.65-0.690.310.8-0.720.710.640.640.420.050.660.8-0.290.690.80.870.610.570.280.64-0.370.61-0.7
-0.13-0.03-0.220.3-0.99-0.290.47-0.12-0.4-0.4-0.87-0.120.0-0.29-0.29-0.29-0.31-0.12-0.3-0.260.27-0.680.16-0.260.29
0.580.190.69-0.90.310.9-0.90.690.780.780.480.370.870.890.69-0.290.910.390.830.710.230.77-0.450.83-0.9
0.650.280.89-0.970.341.0-0.940.680.810.810.470.220.911.00.8-0.310.910.50.910.570.430.79-0.580.9-0.96
0.920.40.32-0.390.120.53-0.410.640.190.190.24-0.020.370.490.87-0.120.390.50.220.520.250.37-0.060.22-0.43
0.40.110.95-0.880.340.88-0.850.390.870.870.390.190.870.920.61-0.30.830.910.220.260.340.7-0.741.0-0.81
0.590.320.14-0.580.240.59-0.610.880.330.330.420.430.470.540.57-0.260.710.570.520.260.090.540.020.25-0.67
0.260.780.49-0.43-0.250.44-0.260.280.170.17-0.21-0.260.450.440.280.270.230.430.250.340.090.06-0.260.36-0.41
0.550.080.63-0.820.720.78-0.910.580.720.720.890.190.630.770.64-0.680.770.790.370.70.540.06-0.230.68-0.82
-0.05-0.01-0.750.46-0.18-0.550.4-0.08-0.62-0.620.01-0.02-0.51-0.61-0.370.16-0.45-0.58-0.06-0.740.02-0.26-0.23-0.740.38
0.40.110.95-0.880.30.88-0.840.390.870.870.360.190.880.920.61-0.260.830.90.221.00.250.360.68-0.74-0.81
-0.61-0.27-0.780.99-0.32-0.960.97-0.77-0.73-0.73-0.51-0.25-0.91-0.95-0.70.29-0.9-0.96-0.43-0.81-0.67-0.41-0.820.38-0.81
Click cells to compare fundamentals

Arch Biopartners Account Relationship Matchups

Arch Biopartners fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets741.3K2.7M621.6K1.2M1.1M588.8K
Other Current Liab269.8K424.8K190K172.5K155.3K160.5K
Total Current Liabilities1.2M3.2M2.8M6.0M6.9M7.2M
Total Stockholder Equity(3.9M)(3.9M)(4.5M)(5.5M)(5.0M)(4.7M)
Net Debt2.7M4.7M3.9M4.2M4.8M5.1M
Retained Earnings(22.1M)(23.3M)(24.7M)(28.1M)(25.2M)(24.0M)
Accounts Payable949.2K962.0K489.4K393.4K452.4K410.7K
Cash653.7K448.2K506.3K831.3K956.0K1.0M
Cash And Short Term Investments653.7K448.2K506.3K831.3K956.0K1.0M
Common Stock Shares Outstanding59.9M61.3M62.2M62.5M71.8M41.8M
Liabilities And Stockholders Equity741.3K2.7M621.6K1.2M1.1M588.8K
Other Current Assets26.6K19.3K28.1K43.0K49.5K39.8K
Other Stockholder Equity4.6M4.7M4.7M6.7M6.0M6.3M
Total Liab4.6M6.6M5.1M6.7M7.7M8.1M
Total Current Assets741.3K2.7M621.6K1.2M1.3M1.4M
Short Long Term Debt Total3.4M5.2M4.4M5.0M5.8M6.1M
Net Receivables61.0K2.2M87.2K296.9K341.4K337.1K
Non Current Liabilities Total3.4M3.4M2.3M703.9K809.5K1.3M
Common Stock13.7M14.8M15.6M15.9M18.3M11.4M
Net Tangible Assets(2.6M)(3.9M)(3.9M)(4.5M)(4.0M)(3.8M)
Long Term Debt3.4M3.4M2.3M703.9K809.5K769.0K
Net Invested Capital(477.7K)1.3M(57.8K)(493.6K)(444.3K)(422.1K)
Net Working Capital(477.7K)(520.8K)(2.2M)(4.8M)(4.3M)(4.1M)
Capital Stock13.7M14.8M15.6M15.9M18.3M15.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arch Stock Analysis

When running Arch Biopartners' price analysis, check to measure Arch Biopartners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Biopartners is operating at the current time. Most of Arch Biopartners' value examination focuses on studying past and present price action to predict the probability of Arch Biopartners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Biopartners' price. Additionally, you may evaluate how the addition of Arch Biopartners to your portfolios can decrease your overall portfolio volatility.